key: cord-1013227-9rdesn88
authors: da Silva, José Claudio; Félix, Valtuir Barbosa; Leão, Sura Amélia Barbosa Felix; Filho, Euclides Maurício Trindade; Scorza, Fulvio Alexandre
title: NEW BRAZILIAN VARIANT OF THE SARS-CoV-2 (P1) OF COVID-19 IN ALAGOAS STATE
date: 2021-05-19
journal: Braz J Infect Dis
DOI: 10.1016/j.bjid.2021.101588
sha: 7b1a9dddc046bc4ce40e92a22ab137293a0bedfb
doc_id: 1013227
cord_uid: 9rdesn88

Since the beginning of 2020, health authorities have been monitoring the cases of Coronavirus Disease 2019 (COVID-19), which has grown every day in Brazil and around the world, becoming pandemic. The new coronavirus, also called SARS-CoV-2 by scientists spreads rapidly, causing fear, deaths, and threats for the economy of several countries. This work aimed to describe the clinical characterization of the first cases of a new Brazilian variant of SARS-CoV-2 (P1) in the State of Alagoas, which occurred on February 16(th), 2021. Two cases are described: first, a person infected in Amazonas State, where the new variant P1 was first described, who migrated to Alagoas State, and second, a case of probable community transmission within Alagoas, since the patient had no history of recent travel. In both confirmed cases the symptoms were mild. Further studies are necessary to better understand the clinical behavior of P1 SARS-CoV-2 variant and also the associated sequelae in the context of COVID-19.

The Coronavirus Disease 2019 has shown to be a disease that may quickly evolve to severe conditions, including death, especially in older people, who are more susceptible to SARS-CoV-2 infection. [1] [2] [3] [4] [5] The COVID-19 virus spreads quickly from person to person, starting clinically as a flu-like syndrome, which may progress to an acute viral pneumonia and severe acute respiratory syndrome, in which there is a need for artificial ventilatory support.

On the other hand, autopsies of patients who died from COVID-19, and also animal models, have shown serious histopathological injuries of the systems. In addition, people who survive from severe infectious have shown sequelae, as respiratory conditions, among others. [5] [6] [7] [8] [9] [10] [11] Studies suggest that expression of ACE2 cellular proteins and TMPRSS2 protease in the olfactory epithelium cells are involved in viral access to the human body and detection in oropharyngeal secretions. 2, 12 Since ACE2 proteins seem to be expressed in significantly higher levels in older people, this may explain the greater susceptibility of this age group to infection. Experiments using machine learning models based on algebraic topology, evaluated the possible changes in the relation between COVID-19 virus and angiotensin 2-converting enzyme receptor host, after confirmation of virus mutations. 10 In this way, studies indicate a higher ability of the mutated virus to infect humans, who will have greater difficulty to control its replication. 13, 14, 15 Researchers have shown that three among six SARS-CoV-2 subtypes have become slightly more infectious, while the other three subtypes have significantly strengthened their infectiousness, bringing greater risks of illness to the general population. 10, 13, 16, 17 This is a descriptive cross-sectional study using public infographics data Amazonas. In this woman, P1 variant infection was also confirmed by genetic sequencing exam. The symptomatic picture of this patient was characterized as mild, as in G#1 patient; however, syptoms as recurrent cough, slight coryza, myalgia and physical asthenia were also observed ( Table 1) . Onset of symptoms began on January 19 th , 2021 with test confirmation on next 25 th , probably on the post-prodromal period. P1 virus seems to be more transmissible, is associated with higher viral loads, and posible reinfections. 18, 19 Epidemiological investigation indicates that these cases (G#1 and G#2 patients) were characterized as allochthonous cases, meaning that the virus was imported from another state. 

This research did not receive any specific grant from funding agencies in the public, private or non-for-profit sectors.

Epidemiology and Transmission of COVID-19 in Shenzhen China: Analysis of 391 cases and 1,286 of their close contacts

Anosmia in COVID-19: Underlying Mechanisms and Assessment of an Olfactory Route to Brain Infection

Expression of the SARS-CoV-2 Entry Proteins, ACE2 and TMPRSS2, in Cells of the Olfactory Epithelium: Identification of Cell Types and Trends with Age

Self-reported Taste and Smell Disorders in Patients with COVID-19: Distinct Features in China

Chemosensory Dysfunction in Patients with COVID-19: What Do We Learn from the Global Outbreak?

A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster

COVID-19 cardiac injury: Implications for long-term surveillance and outcomes in survivors

Simulation of the clinical and pathological manifestations of coronavirus disease 2019 (COVID-19) in golden syrian hamster model: implications for disease pathogenesis and tansmissibility

COVID-19, cytokines, inflammation, and spices: How are they related?

Validation of the GeneXpert Xpress SARS-CoV-2 PCR assay using saliva as biological specimen

High-throughput sequencing of SARS-CoV-2 in wastewater provides insights into circulating variants. medRxiv

Hydroxychloroquine with azithromycin in patients hospitalized for mild and moderate COVID-19

Clinical outcomes of different therapeutic options for COVID-19 in two Chinese case cohorts: A propensityscore analysis

Emerging SARS-CoV-2 mutation hot spots include a novel RNA-dependent-RNA polymerase variant

Characterizing SARS-CoV-2 genome diversity circulating in South American countries: signatures of potentially emergent lineages?

Resurgence of COVID-19 in Manaus, Brazil, despite high seroprevalence. The Lancet

Structure-Function Analyses of New SARS-CoV-2 Variants B.1.1.7, B.1.351 and B.1.1.28.1: Clinical, Diagnostic, Therapeutic and Public Health Implications